GAVI Alliance
 |
|
| Founded | 2000 |
|---|---|
| Type | Public–Private Partnership |
| Legal status | Active |
| Focus | Vaccines against: Human Papillomavirus (HPV), measles rubella, measles second dose, meningococcal A conjugate (Men A), pentavalent (diphtheria-tetanus-pertussis, hepatitis B, Haemophilus influenzae type b), pneumococcal, rotavirus, yellow fever |
| Location |
|
|
Key people
|
Seth Berkley, Dagfinn Høybråten |
| Mission | Saving children’s lives and protecting people’s health by increasing access to immunisation in poor countries |
| Website | www |
Gavi, the Vaccine Alliance (Gavi for short; previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private global health partnership committed to increasing access to immunisation in poor countries.
Gavi brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, civil society, the Bill & Melinda Gates Foundation and other private philanthropists.
Gavi was launched in 2000, at a time when the distribution of vaccines to children in the poorest parts of the world had begun to falter. By the end of the 1990s, immunisation rates were stagnating or even declining. Nearly 30 million children born every year in developing countries were not fully immunised. With a US $750 million commitment from the Bill & Melinda Gates Foundation, the vision of delivering vaccines to these children suddenly came within reach.
Sometime between December 2005 and February 2006, Gavi renamed itself from "Global Alliance for Vaccines and Immunization" to "GAVI Alliance". The latter name was in use until the 2014 rebranding.
The Bill and Melinda Gates Foundation has donated $1.5 billion to the alliance as of January 2013.
Since its launch in 2000, Gavi has contributed to the immunization of an additional 370 million children, helping developing countries prevent more than 5.5 million future deaths from hepatitis B, Haemophilus influenza type B (Hib), measles, pertussis, pneumococcal disease, polio, rotavirus diarrhoea and yellow fever. Between now and 2015, GAVI can accelerate access to new vaccines that will save a further four million lives. This would have a significant impact on achieving the 4th Millennium Development Goal to reduce by two thirds, between 1990 and 2015, the under-five mortality rate by 2015.
Gavi has been promoting the use of pentavalent vaccines all over the world to ensure developing nations have access to global immunization programs. In July 2013, Gavi issued a $700 million bond to purchase vaccines to fight pneumonia and diarrhea, which are two of the most frequent killers of children under the age of five. Gavi will also purchase vaccines for diphtheria, tetanus, pertussis, HIB and hepatitis B. The bond issue will fund immunization efforts supported by Gavi. The transaction was done by the International Finance Facility for Immunisation. Jim Yong Kim, president of the World Bank Group, which is IFFIm’s treasury manager, said that having predictable, long-term funding in place will help them ensure that the world’s most vulnerable children have access to healthcare, and that is a critical step in achieving the goal of ending extreme poverty by 2030.
...
Wikipedia